Learn / Safety & suitability

Who should not use vagus nerve stimulation? Contraindications, precautions, and device-specific limits

The responsible answer depends on the device and the person. A contraindication for an implanted VNS system, a precaution for a cervical device, a study exclusion in taVNS research and a Neuvago product instruction are not interchangeable.

Short answer

Start with the product, not a universal list

There is not one universal VNS contraindication list

Implanted VNS, cervical non-invasive VNS and auricular taVNS use different hardware, stimulation sites, intended uses and product instructions. A rule for one device or modality cannot automatically be transferred to another.

Product instructions come before category-level research

Research can describe adverse events, tolerability and evidence gaps. It cannot by itself create a contraindication for a specific commercial product. Current labeling and product instructions are the authority for product-specific rules.

A precaution is not the same as a contraindication

Some situations call for professional advice or extra caution rather than a blanket prohibition. Limited evidence also does not prove either safety or danger for a group that has not been adequately studied.

Neuvago currently uses an adult general-wellness boundary

Neuvago's current intended-use and Trust & Safety information describe adult wellness use and advise qualified professional input when underlying medical conditions, implanted electronic devices, pregnancy or concerns about electrical stimulation may be relevant.

Four different meanings

Contraindication, precaution, evidence gap and study exclusion should stay separate

CONTRAINDICATION

A defined reason not to use a specific product

A contraindication belongs to the applicable product information or clinical labeling. It should not be inferred from a search result, a study exclusion or the contraindications of another VNS device.

PRECAUTION

A situation that needs extra care or professional input

A precaution can mean checking individual circumstances before use, following additional instructions or stopping if a specific problem occurs. It is not automatically an absolute prohibition.

EVIDENCE GAP

Safety is limited or not established for a population

If pregnant people, children or people with particular medical histories are underrepresented or excluded from studies, the responsible conclusion is that evidence is limited for that population—not that safety or harm has been proven.

STUDY EXCLUSION

A research-design rule, not automatically a product rule

Researchers may exclude participants to reduce confounding or risk in a trial. That decision helps define what the study can support, but it does not automatically become a contraindication for every device in the category.

Device-specific

“VNS” can describe very different technologies

The stimulation site, hardware, intended use, parameters and regulatory context change the safety framework. Shared terminology is not a reason to merge product rules.

SURGICAL / CLINICAL

Implanted VNS

Implanted VNS uses surgically placed hardware and indication-specific clinical labeling. Its contraindications, surgical risks and device interactions belong to that implanted system.

NECK-BASED

Cervical non-invasive VNS

Cervical nVNS stimulates at the neck using product-specific hardware and instructions. Official rules for a prescription cervical device cannot be copied to an auricular wellness product.

EAR-BASED

Auricular taVNS

Auricular stimulation uses contact at the outer ear. Safety interpretation depends on the exact device, contact site, parameters, user instructions and population studied.

Common suitability questions

What current Neuvago information supports—and what it does not

The statements below preserve the difference between a professional-consultation boundary, a product precaution and a categorical contraindication.

Pacemaker or another implanted electronic device

Neuvago's current Trust & Safety information advises people with implanted electronic devices to consult a qualified healthcare professional before use. That is a professional-consultation boundary; this page does not turn it into a universal pacemaker contraindication.

Pregnancy

Neuvago's current Trust & Safety information advises qualified professional input during pregnancy. Research exclusions or limited pregnancy data should be described as an evidence limitation unless current product instructions establish a more specific rule.

Heart rhythm, fainting or other cardiovascular concerns

Underlying medical conditions can require individual clinical judgment. Neuvago's current public information directs users with underlying conditions or concerns about electrical stimulation toward a qualified healthcare professional rather than making a diagnosis or suitability decision online.

Epilepsy or seizure history

Neuvago is not intended to diagnose or treat epilepsy or other medical conditions. A seizure history should not be converted into a categorical Neuvago contraindication from general VNS literature; medical questions belong with an appropriately qualified professional and the current product instructions.

Children and adolescents

Neuvago's current intended-use language describes adult consumers. This page does not extend that intended user group to children or use pediatric research from another product to establish suitability.

Broken, irritated or inflamed skin at the ear

The current Neuvago user manual gives a direct product precaution: avoid using the earpiece on wounds, scars, bruises, abrasions or inflamed skin. This is a product-instruction statement rather than a conclusion borrowed from general VNS research.

Current Neuvago product instructions

Direct instructions should remain direct

The current Neuvago user manual supports the following product-specific handling and stop-use statements. These should not be expanded into unrelated medical contraindications.

  • Use the earpiece in close, even contact with the ear.
  • Avoid using the earpiece on wounds, scars, bruises, abrasions or inflamed skin.
  • Do not place the earpiece in front of or behind the heart during use.
  • Increase intensity slowly and stop immediately if you feel sharp stinging or pain.
  • Discontinue use if you experience lightheadedness, dizziness, chest discomfort or excessive skin irritation.
  • If irritation becomes unpleasant, stop the session. If irritation persists, discontinue use and consult a qualified professional.

Source basis: Neuvago taVNS Device User Manual, version A/1, dated 26 June 2026. Always follow the current instructions supplied with the product.

Research boundary

Safety evidence helps describe the field; it does not create Neuvago contraindications

Safety reviews are useful, but they do not decide individual suitability

Systematic and pooled analyses of taVNS can describe patterns of reported adverse events in studied participants. They do not establish that every device, parameter set or population is equally safe.

Reporting quality matters

A study can report good tolerability while still leaving uncertainty about how adverse events were collected, how long participants were followed and which populations were excluded.

Mostly mild findings do not mean risk-free

A favorable overall safety signal should stay attached to the studied protocols and participants. It is not a guarantee for an individual user and should not replace product-specific instructions.

Missing evidence should remain missing evidence

When safety is limited or not established for a group, the page should say exactly that. It should not silently convert uncertainty into either reassurance or a categorical contraindication.

Comparator devices

Other VNS labels show why product-specific rules matter

Official information for an implanted VNS system and for a cervical non-invasive device contains product-specific safety rules. Those documents are useful here as examples of modality-specific labeling—not as a source of Neuvago rules.

The same principle works in the other direction: a favorable auricular taVNS study cannot erase a contraindication or precaution stated in the current instructions for a particular product.

Neuvago boundary

Read intended use and current safety information together

Neuvago is positioned for adult general-wellness use. It is not intended to diagnose, treat, cure or prevent a disease or to replace professional medical care.

Practical next step

When in doubt, do not fill the gap with a guess

Check the current instructions for the exact device. If your health, an implanted electronic device, pregnancy or another medical circumstance raises a suitability question, consult a qualified healthcare professional when appropriate.

Sources and limits

Product sources define product rules; research defines the evidence context

Sources below have different jobs. Neuvago-owned product and safety information supports Neuvago-specific statements. Peer-reviewed research supports field-level safety context. Official information from other devices illustrates why safety rules are device-specific.

Neuvago taVNS Device User Manual — version A/1

Owned product instructions dated 26 June 2026. Used here only for Neuvago-specific handling, skin/contact, intensity and stop-use instructions.

Open Neuvago source

Neuvago Intended Use

Defines the adult general-wellness purpose, non-medical boundary and professional-care language used for the current product.

Open Neuvago source

Neuvago Trust & Safety

Provides the current professional-consultation boundary for underlying medical conditions, implanted electronic devices, pregnancy and concerns about electrical stimulation.

Open Neuvago source

Kim et al. 2022 — taVNS safety systematic review and meta-analysis

Used for general taVNS safety and adverse-event context, with reporting limitations kept explicit.

Open source

Giraudier et al. 2025 — pooled taVNS side-effect analysis

Used for side-effect and tolerability context in the studied participants, not for universal eligibility.

Open source

Matsuoka et al. 2025 — taVNS safety and parameter review

Used for parameter heterogeneity and limits in safety reporting across taVNS research.

Open source

LivaNova VNS Therapy safety information

An implanted-VNS comparator showing that contraindications and warnings are product- and modality-specific. Its rules are not Neuvago rules.

Open source

gammaCore Sapphire official safety information

Current manufacturer safety information for a cervical nVNS comparator. It is used only to show that restrictions are product- and modality-specific; gammaCore contraindications are not Neuvago rules.

Open source

General educational information only. This page does not diagnose, prescribe treatment or determine individual medical eligibility. Contraindications, warnings, precautions, age limits and other product-specific rules are governed by the current information for the exact device and market.